| KDIGO 2021 clinical practice guideline for the management of glomerular diseases BH Rovin, SG Adler, J Barratt, F Bridoux, KA Burdge, TM Chan, HT Cook, ... Kidney international 100 (4), S1-S276, 2021 | 824 | 2021 |
| Revision of the International Society of Nephrology/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes … IM Bajema, S Wilhelmus, CE Alpers, JA Bruijn, RB Colvin, HT Cook, ... Kidney international 93 (4), 789-796, 2018 | 727 | 2018 |
| C3 glomerulopathy: consensus report MC Pickering, VD D'agati, CM Nester, RJ Smith, M Haas, GB Appel, ... Kidney international 84 (6), 1079-1089, 2013 | 696 | 2013 |
| Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes”(KDIGO) Controversies Conference THJ Goodship, HT Cook, F Fakhouri, FC Fervenza, V Frémeaux-Bacchi, ... Kidney international 91 (3), 539-551, 2017 | 657 | 2017 |
| Membranoproliferative glomerulonephritis—a new look at an old entity S Sethi, FC Fervenza New England Journal of Medicine 366 (12), 1119-1131, 2012 | 603 | 2012 |
| Membranoproliferative glomerulonephritis type II (dense deposit disease): an update GB Appel, HT Cook, G Hageman, JC Jennette, M Kashgarian, ... Journal of the American Society of Nephrology 16 (5), 1392-1403, 2005 | 517 | 2005 |
| Diagnosis of monoclonal gammopathy of renal significance F Bridoux, N Leung, CA Hutchison, G Touchard, S Sethi, JP Fermand, ... Kidney international 87 (4), 698-711, 2015 | 474 | 2015 |
| The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group N Leung, F Bridoux, V Batuman, A Chaidos, P Cockwell, VD D’Agati, ... Nature Reviews Nephrology 15 (1), 45-59, 2019 | 457 | 2019 |
| Diagnosis of IgG4-related tubulointerstitial nephritis Y Raissian, SH Nasr, CP Larsen, RB Colvin, TC Smyrk, N Takahashi, ... Journal of the American Society of Nephrology 22 (7), 1343-1352, 2011 | 456 | 2011 |
| Executive summary of the KDIGO 2021 guideline for the management of glomerular diseases BH Rovin, SG Adler, J Barratt, F Bridoux, KA Burdge, TM Chan, HT Cook, ... Kidney international 100 (4), 753-779, 2021 | 433 | 2021 |
| Rituximab or cyclosporine in the treatment of membranous nephropathy FC Fervenza, GB Appel, SJ Barbour, BH Rovin, RA Lafayette, N Aslam, ... New England Journal of Medicine 381 (1), 36-46, 2019 | 419 | 2019 |
| Transplant glomerulopathy: subclinical incidence and association with alloantibody JM Gloor, S Sethi, MD Stegall, WD Park, SB Moore, S DeGoey, MD Griffin, ... American Journal of Transplantation 7 (9), 2124-2132, 2007 | 416 | 2007 |
| Oxidized omega-3 fatty acids inhibit NF-κB activation via a PPARα-dependent pathway A Mishra, A Chaudhary, S Sethi Arteriosclerosis, thrombosis, and vascular biology 24 (9), 1621-1627, 2004 | 393 | 2004 |
| Biopsy-proven acute interstitial nephritis, 1993-2011: a case series AK Muriithi, N Leung, AM Valeri, LD Cornell, S Sethi, ME Fidler, SH Nasr American Journal of Kidney Diseases 64 (4), 558-566, 2014 | 375 | 2014 |
| C3 glomerulonephritis: clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up S Sethi, FC Fervenza, Y Zhang, L Zand, JA Vrana, SH Nasr, JD Theis, ... Kidney international 82 (4), 465-473, 2012 | 364 | 2012 |
| A proposal for a serology-based approach to membranous nephropathy AS De Vriese, RJ Glassock, KA Nath, S Sethi, FC Fervenza Journal of the American Society of Nephrology 28 (2), 421-430, 2017 | 350 | 2017 |
| New approaches to the treatment of dense deposit disease RJH Smith, J Alexander, PN Barlow, M Botto, TL Cassavant, HT Cook, ... Journal of the American Society of Nephrology 18 (9), 2447-2456, 2007 | 332 | 2007 |
| Renal monoclonal immunoglobulin deposition disease: a report of 64 patients from a single institution SH Nasr, AM Valeri, LD Cornell, ME Fidler, S Sethi, VD D’Agati, N Leung Clinical Journal of the American Society of Nephrology 7 (2), 231-239, 2012 | 321 | 2012 |
| C3 glomerulopathy—understanding a rare complement-driven renal disease RJH Smith, GB Appel, AM Blom, HT Cook, VD D’Agati, F Fakhouri, ... Nature reviews nephrology 15 (3), 129-143, 2019 | 302 | 2019 |
| Renal amyloidosis: origin and clinicopathologic correlations of 474 recent cases SM Said, S Sethi, AM Valeri, N Leung, LD Cornell, ME Fidler, ... Clinical Journal of the American Society of Nephrology 8 (9), 1515-1523, 2013 | 296 | 2013 |
